Initial Case Series With Exalt Single-Use Duodenoscope

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

May 6, 2019

Study Completion Date

June 7, 2019

Conditions
Endoscopic Retrograde Cholangiopancreatography
Interventions
DEVICE

Exalt Model D Single-Use Duodenoscope

Subjects will have a clinically indicated per standard of care ERCP procedure performed with the Exalt single use duodenoscope study device.

Trial Locations (6)

11030

North Shore University Hospital, Manhasset

15213

University of Pittsburgh Medical Center, Pittsburgh

55905

Mayo Clinic, Rochester

90095

Ronald Reagan University of California Los Angeles Medical Center, Los Angeles

98101

Virginia Mason Medical Center, Seattle

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY